Skip to main content
SpringerLink
Log in

The Use of Solid-Phase Chemistry in Therapeutic Drug Monitoring

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Conclusion

Hard data are not yet available to confirm these impressions of the clinical and social usefulness of solid-phase therapeutic drug monitoring. The list of drugs for which it is available is still very short, but preliminary work suggests that other assays will be forthcoming for other drugs, e.g. valproic acid (Halter et al. 1987), quinidine (Nelson et al. 1987) and digoxin (Danielson et al. 1987; Kramer et al. 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Buelteman L, Vistica C, Olson J, Bruno V, Zuk R, et al. An enzyme immunochromatographic assay for the quantitative non-instrumented measurement of phenobarbitals in whole blood. Clinical Chemistry 32: 1064, 1986

    Google Scholar 

  • Burnett D, Goudie JH, Tabossi-Reynolds C. Seralyzer reagent-strip evaluated for measurement of phenobarbital in serum. Clinical Chemistry 33: 191, 1987

    PubMed  CAS  Google Scholar 

  • Chen, R, Li TM, Merrick H, et al. An internal clock reaction used in a one-step enzyme immunochromatographic assay for theophylline in whole blood. Clinical Chemistry 33: 1521–1525, 1987

    PubMed  CAS  Google Scholar 

  • Cheung CM, Soldin SJ. Clinical evaluation of a dry chemistry strip theophylline assay. Therapeutic Drug Monitoring 8: 205–210, 1986

    Article  PubMed  CAS  Google Scholar 

  • Croci D, Nespolo A, Tarenghi G. Quantitative determination of phenobarbital and phenytoin by dry-phase apoenzyme reactivation immunoassay system (ARIS). Therapeutic Drug Monitoring 9: 197–202, 1987

    Article  PubMed  CAS  Google Scholar 

  • Danielson SJ, Detty MR, Alexandrovitch SK. Improved labels for use in digoxin multilayer enzyme immunoassays. Clinical Chemistry 33: 923, 1987

    Google Scholar 

  • Halter CM, Mickelson KE, Wilcox JF, Thompson SG. A dry-reagent immunoassay for valproic acid with the Ames Seralyzer reflectance photometer. Clinical Chemistry 33: 1020, 1987

    Google Scholar 

  • Harding RS, Virapen KV. Evaluation of the ARIS colourimetric phenobarbital assay. Clinical Chemistry 32: 1085, 1986

    Google Scholar 

  • Holford NHG. Therapeutic drug monitoring. In Speight (Ed.) Avery’s Drug Treatment, pp. 194–222, ADIS Press, Auckland, 1987

    Google Scholar 

  • Kramer DL, Woodrum DL, Coty WA, Zipp AP. OASIS: automated solid-phase immunoassay system for the decentralised laboratory. Clinical Chemistry 33: 1571–1572, 1987

    Google Scholar 

  • Kung C, Osorio B, Mundy K, Ginsberg V, Wong E, et al. An enzyme immunochromatographic assay for the quantitative non-instrumental measurement of phenytoin in whole blood. Clinical Chemistry 32: 1074–1075, 1986

    Google Scholar 

  • Litman DI, Lee RH, Jeong HJ, Tom HK, Stisio SN, et al. An internally referenced test strip immunoassay for morphine. Clinical Chemistry 29: 1598–1603, 1986

    Google Scholar 

  • Marks V. Therapeutic drug monitoring. In Marks & Alberti (Eds) Clinical biochemistry nearer the patient, pp. 190–194, Churchill Livingstone, Edinburgh, 1985

    Google Scholar 

  • Marks V, Lindup WE, Bayliss EM. Measurement of therapeutic agents in blood. Advances in Clinical Chemistry 16: 47–109, 1973

    Article  PubMed  CAS  Google Scholar 

  • Massoud N, Munzenberger P, Sarmak A. Comparison of the seralyzer and EMIT systems for determination of theophylline concentrations. American Journal of Hospital Pharmacy 43: 1722–1726, 1986

    PubMed  CAS  Google Scholar 

  • Morris DL, Ellis PB, Hornby WE. Flavin adenine dinucleotide as a label in homogenous colorimetric immunoassays. Analytical Chemistry 53: 658–665, 1981

    Article  PubMed  CAS  Google Scholar 

  • Mould GP. Drug monitoring and clinical pharmacy. British Journal of Pharmaceutical Practice 3: 22–24, 1981

    Google Scholar 

  • Mould GP, Aherne GW, Morris BA, Teale JD, Marks V. Radioimmunoassay of drugs and its clinical application. European Journal of Drug Metabolism and Pharmacokinetics 4: 171–184, 1977

    Article  Google Scholar 

  • Nelson CD, Acrey CD, Clayborn JK, Clements HM, Messenger KK, et al. A dry reagent strip for the determination of quinidine with the Ames Seralyzer reflectance photometer. Clinical Chemistry 33: 1017, 1987

    Google Scholar 

  • Nguyen QC, Sly RM, Boeckx RL, Kelly HA. Evaluation of determinations of theophylline concentrations by Seralyzer. Annals of Allergy 57: 147–149, 1986

    PubMed  CAS  Google Scholar 

  • Norton GE, Mauck JB. Development of a Kodak Ektachem clinical chemistry slide assay for theophylline. Clinical Chemistry 31: 911, 1985

    Google Scholar 

  • Patsalos PN, Sander JWAS, Oxley J, Lascelles PT. Immediate anticonvulsive monitoring in management of epilepsy. Lancet 2: 39, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rupchock P, Sommer R, Greenquist A, Tyhach R, Walter B, et al. Dry reagent strips used for determination of theophylline in serum. Clinical Chemistry 31: 737–740, 1985

    PubMed  CAS  Google Scholar 

  • Sheehan M, Caron G, Salmon J. Evaluation of a dry reagent strip test for phenobarbital. Clinical Chemistry 32: 1084, 1986

    Google Scholar 

  • Stanley PE. Who and where? In Richens & Marks (Eds) Therapeutic drug monitoring, pp. 54–60, Churchill Livingstone, Edinburgh, 1981

    Google Scholar 

  • Tabossi-Reynolds C, Ayers G, Goudie JH, Burnett D. Evaluation of the Seralyzer reagent test strip system for the measurement of serum carbamazepine. Annals of Clinical Biochemistry 24 (Suppl. S1): 65–66, 1987

    Google Scholar 

  • Tyhach RJ, Rupchock PA, Pendergrass JH. Adaption of prosthetic group-label homogenous immunoassay to reagent strip format. Clinical Chemistry 27: 1449–1504, 1981

    Google Scholar 

  • Vožeh S. Cost-effectiveness of therapeutic drug monitoring. Clinical Pharmacokinetics 13: 131–140, 1987

    Article  PubMed  Google Scholar 

  • Walter B, Greenquist AC, Howard HI WE. Solid-phase reagent strips for detection of therapeutic drugs in serum by substrate-labelled fluorescent immunoassay. Analytical Chemistry 55: 873–878, 1983

    Article  PubMed  CAS  Google Scholar 

  • Zuk RF, Ginsberg VK, Houts T, Rabbie J, Merrick H, et al. Enzyme immunochromatography: a quantitative immunoassay requiring no instrumentation. Clinical Chemistry 31: 1144–1150, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry and Clinical Nutrition, St Lukes Hospital, Warren Road, Guildford, England

    G. Mould &  V. Marks

Authors
  1. G. Mould
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mould, G., Marks, V. The Use of Solid-Phase Chemistry in Therapeutic Drug Monitoring. Clin-Pharmacokinet 14, 65–70 (1988). https://doi.org/10.2165/00003088-198814020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198814020-00001

Search

Navigation